EP 0785777 A4 19970730 -
Publication
Application
Priority
- US 9407817 W 19940712
- US 9038793 A 19930712
Abstract (en)
[origin: WO9502396A1] This invention relates to a pharmaceutically acceptable preparation comprising one or more matrix-forming materials in which are entrapped particles which contain at least one beneficial agent.
IPC 1-7
IPC 8 full level
A61K 9/16 (2006.01); A61K 9/00 (2006.01); A61K 9/20 (2006.01); A61K 9/26 (2006.01)
CPC (source: EP KR)
A61K 9/0056 (2013.01 - EP); A61K 9/20 (2013.01 - KR); A61K 9/2081 (2013.01 - EP)
Citation (search report)
- [XYY] WO 9013323 A1 19901115 - BAXTER INT [US]
- [A] EP 0241615 A1 19871021 - WARNER LAMBERT CO [US]
- [A] US 4963359 A 19901016 - HASLWANTER JOSEPH [US], et al
- [A] EP 0418596 A2 19910327 - AMERICAN CYANAMID CO [US]
- See references of WO 9502396A1
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9502396 A1 19950126; AU 684528 B2 19971218; AU 7258094 A 19950213; CA 2167050 A1 19950126; CN 1130867 A 19960911; CZ 6696 A3 19960612; EP 0785777 A1 19970730; EP 0785777 A4 19970730; FI 960133 A0 19960111; FI 960133 A 19960311; HU 9600048 D0 19960328; HU T73666 A 19960930; JP H09500135 A 19970107; KR 960703572 A 19960831; NO 960098 D0 19960109; NO 960098 L 19960220; NZ 269103 A 19970922; PL 312503 A1 19960429; SK 3396 A3 19970409; ZA 944949 B 19950405
DOCDB simple family (application)
US 9407817 W 19940712; AU 7258094 A 19940712; CA 2167050 A 19940712; CN 94193367 A 19940712; CZ 6696 A 19940712; EP 94922131 A 19940712; FI 960133 A 19960111; HU 9600048 A 19940712; JP 50466995 A 19940712; KR 19960700229 A 19960112; NO 960098 A 19960109; NZ 26910394 A 19940712; PL 31250394 A 19940712; SK 3396 A 19940712; ZA 944949 A 19940708